How GLP-1 Medications & Exercise Impact Migraine: Two Experts Weigh In
Interview Notes – COMING SOON
- Dale Bond, PhD & Devika Umashanker, MS, MBA, MD
Treatments Mentioned – COMING SOON
Please note: The Migraine World Summit’s aim is to bring you a variety of perspectives and expertise, independent of bias or judgment. Alternative theories presented in this video have not been medically reviewed. Views expressed in this interview do not necessarily represent the views of the Migraine World Summit. Please always consult your health care professional and do your own research before making changes to your treatment plan.
Dale Bond, PhD & Devika Umashanker, MS, MBA, MD
Director of Research Integration; System Medical Director, Obesity Medicine
Hartford Healthcare
Dr. Dale Bond is director of research integration at Hartford HealthCare and co-director of the Hartford HealthCare Digestive Health Institute’s Center for Obesity Research, Innovation, and Education. His research involves assessing and intervening on health behaviors in the context of obesity and related conditions (including migraine) and treatments (metabolic bariatric surgery, obesity-modifying medications, and lifestyle interventions). With grants awarded by the National Institutes of Health and other organizations, he has served as principal and co-investigator on several prospective observational studies and randomized clinical trials pursuant to the advancement of these areas. Of note, he has also conducted seminal studies focused on the interrelationships of migraine with physical activity, obesity, and weight loss.
Dr. Devika Umashanker is the system medical director for obesity medicine at Hartford HealthCare Medical and Surgical Weight Loss, Hartford HealthCare Digestive Health Institute. She is an associate professor of internal medicine at the Frank H. Netter School of Medicine, Quinnipiac University, and the program director of the Obesity Medicine Fellowship at Hartford Healthcare. She is board certified in internal medicine and fellowship trained in obesity medicine at NewYork-Presbyterian Weill Cornell Medical Center.
Dr. Umashanker’s primary areas of expertise include weight management, preoperative weight loss, and post-operative bariatric surgical care and nutrition management. Her research focus includes optimization of nonsurgical treatment modalities in patients with a history of bariatric surgery and obesity, association of weight stigma and bias on patient clinical outcomes, and prevalence of migraine in patients seeking treatment in medical and surgical weight loss. Dr. Umashanker was awarded the 2023 Integrated Health Emerging Scientist Award by the International Federation for the Surgery of Obesity and Metabolic Disorders.
Dr. Umashanker has written several publications and book chapters on the topics of obesity management and treatment, pharmacotherapy for obesity, and weight stigma and bias.
Pre-purchase full access to the entire [YEAR] Summit, including:
Related Talks for: Day 7 (2025)
What We Know About the Biology of Migraine
Jessica Ailani, MD, FAHS, FAAN
Can Pain Reprocessing Therapy Offer Migraine Relief?
Alan Gordon, LCSW
